Figure 4From: Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro Western blot analysis of protein expression of T24 cells treated with sunitinib malate. T24 cells were exposed to sunitinib (1.25 μmol/L, 2.5 μmol/L, 5 μmol/L and 10 μmol/L) for 48 hours, and western blot analysis with antibodies specific for Fas, FasL, PARP and β-actin is shown. β-Actin levels are shown as an internal control.Back to article page